Publicacions (27) Publicacions de David Bartolomé Martín

2021

  1. Activation of SGK1.1 Upregulates the M-current in the Presence of Epilepsy Mutations

    Frontiers in Molecular Neuroscience, Vol. 14

  2. Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 23, pp. 7733-7756

  3. Regulation of the voltage-dependent sodium channel NaV1.1 by AKT1

    Neuropharmacology, Vol. 197

2020

  1. Differential regulation of BK channels by fragile X mental retardation protein

    Journal of General Physiology, Vol. 152, Núm. 6

  2. β-adrenergic receptors/epac signaling increases the size of the readily releasable pool of synaptic vesicles required for parallel fiber LTP

    Journal of Neuroscience, Vol. 40, Núm. 45, pp. 8604-8617

2019

  1. Activity dependent internalization of the glutamate transporter GLT-1 requires calcium entry through the NCX sodium/calcium exchanger

    Neurochemistry International, Vol. 123, pp. 125-132

  2. Identification of potassium channel proteins Kv7.2/7.3 as common partners of the dopamine and glutamate transporters DAT and GLT-1

    Neuropharmacology, Vol. 161

  3. Photoconversion of FM1-43 Reveals Differences in Synaptic Vesicle Recycling and Sensitivity to Pharmacological Disruption of Actin Dynamics in Individual Synapses

    ACS Chemical Neuroscience, Vol. 10, Núm. 4, pp. 2045-2059

2018

  1. Identification of novel regulatory partners of the glutamate transporter GLT-1

    GLIA, Vol. 66, Núm. 12, pp. 2737-2755

2017

  1. CB1 receptors down-regulate a cAMP/Epac2/PLC pathway to silence the nerve terminals of cerebellar granule cells

    Journal of Neurochemistry, Vol. 142, Núm. 3, pp. 350-364

  2. Glycine transporters and its coupling with NMDA receptors

    Advances in Neurobiology (Springer New York LLC), pp. 55-83

  3. P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2

    Neuropharmacology, Vol. 125, pp. 99-116

2016

  1. Cross-talk between metabotropic glutamate receptor 7 and beta adrenergic receptor signaling at cerebrocortical nerve terminals

    Neuropharmacology, Vol. 101, pp. 412-425

2015

  1. Rescue of homeostatic regulation of striatal excitability and locomotor activity in a mouse model of huntington's disease

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 7, pp. 2239-2244

2014

  1. Cannabinoid type 1 receptors transiently silence glutamatergic nerve terminals of cultured cerebellar granule cells

    PLoS ONE, Vol. 9, Núm. 2

2013

  1. Potentiation of mGlu7 receptor-mediated glutamate release at nerve terminals containing N and P/Q type Ca2+ channels

    Neuropharmacology, Vol. 67, pp. 213-222

  2. Studying synaptic efficiency by post-hoc immunolabelling

    BMC Neuroscience, Vol. 14

  3. β-adrenergic receptors activate exchange protein directly activated by cAMP (Epac), translocate munc13-1, and enhance the Rab3A-RIM1 α interaction to potentiate glutamate release at cerebrocortical nerve terminals

    Journal of Biological Chemistry, Vol. 288, Núm. 43, pp. 31370-31385

2012

  1. Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation

    Neurochemistry International, Vol. 61, Núm. 1, pp. 119-127

  2. Efficient synaptic vesicle recycling after intense exocytosis concomitant with the accumulation of non-releasable endosomes at early developmental stages

    Journal of Cell Science, Vol. 125, Núm. 2, pp. 422-434